Guizhou BaiLing Enterprise Group Pharmaceutical Co., Ltd.
2019-2021 Annual Financial Report
[Image: BaiLing Bird logo]
Balance Sheet (Assets)
| Item | Note | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|
| Consolidated | Parent Company | Consolidated | ||
| Current Assets: | ||||
| Cash and cash equivalents | 1 | 465,625,063.55 | 275,461,233.95 | 1,030,959,946.21 |
| Financial assets held for trading | 2 | 4,750,000.00 | ||
| Derivatives financial assets | 3 | |||
| Notes receivable | 4 | 1,573,975,166.17 | 1,039,101,322.37 | 1,504,485,990.94 |
| Accounts receivable | 5 | 401,968,072.65 | 249,988,196.06 | 595,930,961.77 |
| Receivable financing | 6 | 32,903,983.05 | 19,732,108.07 | 114,177,638.11 |
| Prepayments | 7 | 196,890,374.22 | 805,889,240.26 | 558,096,675.14 |
| Other receivables | 8 | 825,127,565.36 | 718,357,769.96 | 769,998,982.03 |
| Inventory | ||||
| Of which: Data resources | ||||
| Contract assets | ||||
| Assets held for sale | ||||
| Non-current assets due within one year | ||||
| Other current assets | 9 | 2,012,251.06 | 7,855,628.67 | |
| Total current assets | 3,503,252,476.06 | 3,113,279,870.67 | 4,581,505,822.87 | |
| Non-current assets: | ||||
| Debt investments | 10 | |||
| Other debt investments | ||||
| Long-term receivables | ||||
| Long-term equity investments | 11 | 1,114,023,667.70 | 1,613,200,165.66 | 1,113,407,508.55 |
| Other equity instruments investments | ||||
| Other non-current financial assets | 12 | 359,196,600.00 | 359,196,600.00 | 225,333,300.00 |
| Investment properties | 13 | 27,874,600.16 | 27,874,600.16 | 30,535,634.84 |
| Fixed assets | 14 | 803,453,023.88 | 635,034,735.24 | 654,660,738.27 |
| Construction in progress | 15 | 77,916,394.96 | 77,688,524.36 | 15,889,334.59 |
| Productive biological assets | 16 | 9,174,208.21 | 9,174,208.21 | 12,186,432.17 |
| Oil and gas assets | ||||
| Right-of-use assets | 17 | |||
| Intangible assets | 18 | 73,183,543.95 | 2,874,204.28 | 133,391,688.96 |
| Of which: Data resources | ||||
| Development expenditures | ||||
| Of which: Data resources | ||||
| Goodwill | 19 | 20,583,856.73 | 20,583,856.73 | |
| Long-term deferred expenses | 20 | 30,030,453.27 | 1,068,692.94 | 44,206,745.74 |
| Deferred tax assets | 21 | 179,022,731.65 | 155,637,696.94 | 159,261,916.19 |
| Other non-current assets | 22 | 54,291,422.90 | 51,501,702.90 | 30,054,936.59 |
| Total non-current assets | 3,082,756,814.08 | 3,140,133,490.99 | 2,550,154,335.04 | |
| Total assets | 6,586,009,290.14 | 6,253,413,361.66 | 7,131,660,157.91 | |
| Legal Representative: | [blank] | [blank] | ||
| Person in charge of accounting work: | [blank] | [blank] | ||
| Person in charge of accounting department: | [blank] | [blank] |